Lv3
220 积分 2024-10-28 加入
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
18天前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
18天前
已完结
Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis
25天前
已完结
Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials
25天前
已完结
Urinary tract infections and genital mycotic infections associated with SGLT‑2 inhibitors: an analysis of the FDA Adverse Event Reporting System
25天前
已完结
Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial
25天前
已完结
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
1个月前
已完结
Diagnosis, management and outcomes of primary hypokalemic periodic paralysis during pregnancy
1个月前
已完结
Thyrotoxic Periodic Paralysis
1个月前
已完结
Enterococcus faecalis
2个月前
已完结
皖公网安备34019202002308
